These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4921585)

  • 21. Levodopa therapy for Parkinson's disease. A first-year experience with outpatients in private practice.
    McFarland HR
    Mo Med; 1971 Nov; 68(11):843-7. PubMed ID: 5096631
    [No Abstract]   [Full Text] [Related]  

  • 22. Synergism of levodopa by alpha methyldopa.
    Fermaglich J; O'Doherty DS
    Trans Am Neurol Assoc; 1971; 96():231-4. PubMed ID: 5159089
    [No Abstract]   [Full Text] [Related]  

  • 23. Side effects from levodopa.
    Ray I
    Can Med Assoc J; 1972 Jul; 107(1):19. PubMed ID: 5042883
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: Long term mental changes in levodopa-treated patients.
    Botez MI; Barbeau A
    Lancet; 1973 Nov; 302(7836):1028-9. PubMed ID: 4127251
    [No Abstract]   [Full Text] [Related]  

  • 25. Levodopa in treating Parkinsonism.
    O'Doherty DS
    Am Fam Physician; 1971 Nov; 4(5):95-9. PubMed ID: 5117507
    [No Abstract]   [Full Text] [Related]  

  • 26. [Levodopa and Parkinsonism. A double-blind study].
    Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
    Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
    Barbieri NF; Megna GF; Micalizzi V; Pigneri MT; Puca FM
    Minerva Med; 1971 Oct; 62(82):4000-3. PubMed ID: 5125063
    [No Abstract]   [Full Text] [Related]  

  • 28. Levodopa effect upon functional balance of Parkinson's disease patients.
    Nova IC; Perracini MR; Ferraz HB
    Parkinsonism Relat Disord; 2004 Oct; 10(7):411-5. PubMed ID: 15465397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Theray of Parkinson-syndrome with Helfo-Dopa].
    Roeder F
    Med Klin; 1970 Nov; 65(45):1983-7. PubMed ID: 5520307
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Neurology; 1970 Apr; 20(4):376-7. PubMed ID: 4935022
    [No Abstract]   [Full Text] [Related]  

  • 31. Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Koh CV; Ananth JV; Ban TA; Lehmann HE
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):289-91. PubMed ID: 4931413
    [No Abstract]   [Full Text] [Related]  

  • 32. Convulsive seizures and electroencephalogram changes in three patients during levodopa therapy.
    McPherson A
    Neurology; 1970 Dec; 20(12):41-5. PubMed ID: 5531293
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple primary melanoma following administration of levodopa.
    Skibba JL; Pinckley J; Gilbert EF; Johnson RO
    Arch Pathol; 1972 Jun; 93(6):556-61. PubMed ID: 5025039
    [No Abstract]   [Full Text] [Related]  

  • 34. The clinical pharmacology of levodopa.
    Morgan JP; Bianchine JR
    Ration Drug Ther; 1971 Jan; 5(1):1-8. PubMed ID: 5162935
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa and physical therapy in treatment of patients with Parkinson's disease.
    Stern PH; McDowell F; Miller JM; Robinson M
    Arch Phys Med Rehabil; 1970 May; 51(5):273-7. PubMed ID: 5420013
    [No Abstract]   [Full Text] [Related]  

  • 36. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P; Oakes D; Cui L
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU; Stam FC; Meerlo HJ
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):701-7. PubMed ID: 5551426
    [No Abstract]   [Full Text] [Related]  

  • 38. Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(5):367-70. PubMed ID: 4998432
    [No Abstract]   [Full Text] [Related]  

  • 39. L-dopa and frontal cognitive function in Parkinson's disease.
    Lange KW; Paul GM; Robbins TW; Marsden CD
    Adv Neurol; 1993; 60():475-8. PubMed ID: 8420173
    [No Abstract]   [Full Text] [Related]  

  • 40. "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.
    Vázquez A; Jiménez-Jiménez FJ; García-Ruiz P; García-Urra D
    Acta Neurol Scand; 1993 Jan; 87(1):14-8. PubMed ID: 8424307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.